Hematology

Anticoagulation Considerations in Critically Ill Oncology Patients

Bonus Session Available in Congress Digital

Location: Congress Digital

Bonus CE Session Faculty(s)

HM

Heather May, BCCCP, PharmD, FCCM

Mayo Clinic
Rochester, Minnesota

Describe limitations of VTE management, antiplatelet and anticoagulation considerations in critically ill oncology patients including theoretical hold considerations, preferred agents, and risk benefit evaluation